ESC Professional Premium Access

SGLT2 inhibitor for secondary prevention in acute myocardial infarction patients with diabetes mellitus

Congress Presentation

About the speaker

Professor Dongbin Kim

The Catholic University of Korea, Seoul (Korea (Republic of))
1 follower

7 more presentations in this session

Effect of evolocumab on platelet function in patients with acute coronary syndromes. An analysis of the randomized, double-blind, placebo-controlled EVOPACS Trial

Speaker: Doctor K. Koskinas (Bern, CH)


ARCANGELO: an observational, prospective study with acute coronary syndrome patients undergoing percutaneous coronary intervention who receive cangrelor transitioning to oral P2Y12 inhibitors

Speaker: Doctor L. De Luca (Pavia, IT)


Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis

Speaker: Doctor S. Al Said (Boston, US)


The effect of sodium-glucose co-transporter-2 inhibitors following anterior ST-segment elevation myocardial infarction

Speaker: Doctor G. Incesu (Istanbul, TR)


Comparison of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in myocardial infarction patients with type 2 diabetes

Speaker: Doctor J. Tjerkaski (Stockholm, SE)


Access the full session

Treatment of acute coronary syndromes in clinical practice

Speakers: Professor D. Kim, Doctor K. Koskinas, Doctor L. De Luca, Doctor S. Al Said, Doctor G. Incesu...

About the event


ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb